1. Coptidis rhizoma and evodiae fructus against lipid droplet deposition in nonalcoholic fatty liver disease‐related liver cancer by AKT
    Shenghao Li et al, 2023, Chemical Biology & Drug Design CrossRef
  2. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification
    Shenghao Li et al, 2023, Infectious Agents and Cancer CrossRef
  3. Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma
    Yinglin Guo et al, 2022, The FASEB Journal CrossRef
  4. Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System
    Aadil Javed et al, 2022, Future Pharmacology CrossRef
  5. PD-1/PD-L1 Interaction Upregulates YAP1 Expression in HepG2 Cells Through MAPK/ERK Pathway
    Shenghao Li et al, 2023, Natural Product Communications CrossRef
  6. Target prediction and potential application of dihydroartemisinin on hepatocarcinoma treatment
    Wenjia Guo et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  7. KNTC1 knockdown inhibits proliferation and metastases of liver cancer
    Fan Yang et al, 2023, 3 Biotech CrossRef
  8. Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma
    Qing Peng et al, 2023, Journal of Natural Medicines CrossRef
  9. Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti‐PD‐1 efficacy
    Qing Peng et al, 2023, Phytotherapy Research CrossRef
  10. Effects of Sodium Chromate Exposure on Gene Expression Profiles of Primary Rat Hepatocytes (In Vitro)
    Xiaofeng Li et al, 2023, Biological Trace Element Research CrossRef
  11. Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis
    Qiannan Gao et al, 2022, Frontiers in Molecular Biosciences CrossRef
  12. A Systematic Study of Traditional Chinese Medicine for the Treatment of Lung Adenocarcinoma Using a Reverse Network of Key Targets Based on Bioinformatics and Molecular Docking: Curcumin and Trans-Resveratrol as Potential Drug Candidates for Lung Adenocarcinoma
    Wujun Wang et al, 2023, Natural Product Communications CrossRef
  13. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis
    Yu Qiao et al, 2022, Cancer Biomarkers CrossRef
  14. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8+ effector T cells in hepatocellular carcinoma
    Yuting Gao et al, 2024, Biochemical Pharmacology CrossRef